Lima Memorial Health System Logo
Approximate ER WAIT TIME
5

Health Library

Cryotherapy for prostate cancer
     
Print-Friendly
Bookmarks

Cryotherapy for prostate cancer

Cryosurgery - prostate cancer; Cryoablation - prostate cancer

 

Cryotherapy uses very cold temperatures to freeze and kill prostate cancer cells. The goal of cryosurgery is to destroy the entire prostate gland and possibly surrounding tissue.

Cryosurgery is generally not used as a first treatment for prostate cancer.

What Happens During Cryotherapy

 

Before the procedure, you will be given medicine so that you do not feel pain. You may receive:

  • A sedative to make you drowsy and numbing medicine on your perineum. This is the area between the anus and scrotum.
  • Anesthesia. With spinal anesthesia, you will be drowsy but awake, and numb below the waist. With general anesthesia, you will be asleep and pain-free.

First, you will get a urinary catheter that will stay in place for about 3 weeks after the procedure.

  • During the procedure, the surgeon places needles through the skin of the perineum into the prostate.
  • Ultrasound is used to guide the needles to the prostate gland.
  • Then, very cold gas passes through the needles, creating ice balls that destroy the prostate gland tissue.
  • Warm salt water will flow through the catheter to keep your urethra (the tube from the bladder to outside the body) from freezing.

Cryosurgery is most often a 2-hour outpatient procedure. Some people may need to stay in the hospital overnight.

 

When Cryosurgery is Used to Treat Prostate Cancer

 

This therapy is not as commonly used and is not as well accepted as other treatments for prostate cancer. Doctors do not know for certain how well cryosurgery works over time. There is not enough data to compare it with standard prostatectomy, radiation treatment, or brachytherapy.

It can only treat prostate cancer that has not spread beyond the prostate. Men who cannot have surgery because of their age or other health problems may have cryosurgery instead. It also may be used if cancer comes back after other treatments.

It is generally not helpful for men with very large prostate glands.

 

Side Effects

 

Possible short-term side effects of cryotherapy for prostate cancer include:

  • Blood in the urine
  • Trouble passing urine
  • Swelling of the penis or scrotum
  • Problems controlling your urination (more likely if you have had radiation therapy also)

Possible long-term problems include:

  • Erection problems in nearly all men
  • Damage to the rectum
  • A tube that forms between the rectum and the bladder, called a fistula (this is very rare)
  • Problems with passing urine or controlling urination
  • Scarring of the urethra and difficulty urinating

 

 

References

American Cancer Society website. Cryotherapy for prostate cancer. www.cancer.org/cancer/prostate-cancer/treating/cryosurgery.html. Updated November 22, 2023. Accessed January 18, 2024.

National Cancer Institute website. Cryosurgery to treat cancer. www.cancer.gov/about-cancer/treatment/types/surgery/cryosurgery. Updated June 21, 2021. Accessed January 18, 2024.

National Cancer Institute website. Prostate cancer treatment (PDQ) - health professional version. www.cancer.gov/types/prostate/hp/prostate-treatment-pdq. Updated February 13, 2023. Accessed January 18, 2024.

National Comprehensive Cancer Network website. NCCN clinical practice guidelines in oncology (NCCN guidelines): prostate cancer. Version 4.2023. www.nccn.org/professionals/physician_gls/pdf/prostate.pdf. Updated September 7, 2023. Accessed January 18, 2024.

BACK TO TOPText only

 
  • Prostate cancer

    Animation

  • Male reproductive anatomy

    Male reproductive anatomy

    illustration

  • Prostate cancer

    Animation

  • Male reproductive anatomy

    Male reproductive anatomy

    illustration

A Closer Look

 

Talking to your MD

 

    Self Care

     

      Tests for Cryotherapy for prostate cancer

       
         

        Review Date: 10/15/2023

        Reviewed By: Kelly L. Stratton, MD, FACS, Associate Professor, Department of Urology, University of Oklahoma Health Sciences Center, Oklahoma City, OK. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

        The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, timeliness, or correctness of any translations made by a third-party service of the information provided herein into any other language. © 1997- A.D.A.M., a business unit of Ebix, Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
        © 1997- adam.comAll rights reserved.